Advertisement

WHO Issues Its First Guidelines for Managing Hepatitis C Infection — Physician’s First Watch

Medical News |
April 10, 2014

WHO Issues Its First Guidelines for Managing Hepatitis C Infection

By Kelly Young

The World Health Organization has issued its first recommendations on screening for and treating hepatitis C infection.

Among the recommendations:

  • Patients at high risk should receive an initial screening. Those who screen positive should be tested again to determine whether their infection is chronic.

  • Patients with chronic infection should receive an alcohol assessment, and those with moderate-to-high alcohol use should be offered a behavioral intervention to reduce intake.

  • Pegylated interferon with ribavirin is the recommended treatment.

The authors also make specific treatment recommendations based on HCV genotype.

Reader Comments (1)

Dr. Physician, Dermatology, new mowasat hospital

Important guidelines

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement